Abstract
Female SD rats with established 7, 12-dimethylbenz [a]anthracene(DMBA)-induced mammary tumours were treated with coumarin (20 mg/kg body weight; six times per week) or its metabolite 7-hydroxycoumarin (20 mg/kg) for 4 weeks. The anti-oestrogen tamoxifen (8.8 mg/kg) served as the reference drug. The inhibitory effect of coumarin was similar to that of tamoxifen [mean change of tumour area: 428% (coumarin) compared to 528% (tamoxifen); control 822%]. The strongest inhibition was observed with 7-hydroxycoumarin (248%); the difference compared to the control was significant (P<0.01). Neither coumarin nor 7-hydroxycoumarin reduced the number of tumours appearing during treatment as tamoxifen did. However, the size of the tumours treated with coumarin or its metabolite was generally much smaller than those in the tamoxifen group or in the control group. From the data obtained it appears that coumarin and 7-hydroxycoumarin inhibit the growth of tumours that have reached a certain size but do not prevent the formation of tumours after exposure to the carcinogen.
This is a preview of subscription content, log in via an institution to check access.
References
Angerer E von, Prekajac J, Strohmeier J (1984) 2-Phenylindoles. Relationship between structure, estrogen receptor affinity, and mammary tumor inhibiting activity in the rat. J Med Chem 27:1439–1447
Feuer G, Kellen JA (1974) Link between carcinogenicity and hepatic metabolism of 7,12-dimethylbenz[a]anthracene. Oncology 30:499–508
Fiebig HH, Schmähl D (1980) Endocrine and cytostatic treatment of experimental mammary cancer. In: Henningsen B, Linder F, Steichele C (eds) Endocrine treatment of breast cancer. Springer, Berlin Heidelberg New York pp 80–95
Kokron O, Maca S, Gasser G, Schmidt RR (1991) Cimetidine und coumarin therapy of renal cell carcinoma. A pilot study. Oncology 48:102–106
Marshall ME, Riley LK, Rhoades J, Eicchorn T, Jennings CD, Cibull M, Thompson J (1989) Effects of coumarin (1,2-benzopyrone) and cimetidine on peripheral blood lymphocytes, natural killer cells, and monocytes in patients with advanced malignancies. J Biol Response Mod 8:62–69
Maucher A (1992) Pharmakologische Untersuchungen über neue Möglichkeiten zur endokrinen und cytostatischen Behandlung des Prostatakarzinoms, PhD Thesis Regensburg
Maucher A, Kager M, von Angerer E (1993) Evaluation of the antitumour activity of coumarin in prostate cancer models. J Cancer Res Clin Oncol 119:150–154
Moran E, Prosser E, O'Kennedy R, Thornes RD (1993) The effect of coumarin and 7-hydroxycoumarin on the growth of human tumour cell lines. J Ir Coll Physicians Surg 22[Suppl 1]:41–43
Rosskopf F, Kraus J, Franz G (1992) Immunological and antitumor effects of coumarin and some derivatives. Pharmazie 47:139–142
Stuhlmeier K, Theyer G, Baumgartner G, Zlabinger GJ (1991) Synergistic effect of coumarin (1,2 benzopyrone) and endotoxin in the induction of human interleukin-1. Clin Exp Immunol 84:317–323
Thornes D, Daly L, Lynch G, Browne H, Tanner A, Keane F, O'Loughlin S, Corrigan T, Daly P, Edwards G, Breslin B, Shine M, Lennon F, Hanley J, McMurray N, Gaffney E (1989) Prevention of early recurrence of high risk malignant melanoma by coumarin. Eur J Surg Oncol 15:431–435
Wakeling AE (1991) Steroidal pure antiestrogens. In: Lippman M, Dickson R (eds) Regulatory mechanisms in breast cancer. Kluwer Academic Publishers, Boston, pp 239–257
Wattenberg LW, Lam LKT, Fladmoe AV (1979) Inhibition of chemical carcinogen-induced neoplasia by coumarins and α-angelicalactone. Cancer Res 39:1651–1654
Zänker KS, Blumei G, Lange J (1984) Coumarin in melanoma patients: an experimental and clinical study. Drug Exp Clin Res 20:767–774
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Dr. H.J. Roth on the occasion of his 65th birthday
Rights and permissions
About this article
Cite this article
Maucher, A., von Angerer, E. Antitumour activity of coumarin and 7-hydroxycoumarin against 7, 12-dimethylbenz[a]anthracene-induced rat mammary carcinomas. J Cancer Res Clin Oncol 120, 502–504 (1994). https://doi.org/10.1007/BF01191806
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01191806